Limits on Use of Adimab Materials. Arsanis understands and agrees that Adimab Materials may have unpredictable and unknown chemical properties, that they are to be used with caution, and that, except as expressly permitted by Article 3 (License and Assignment; Development & Commercialization) following exercise of the Option, they are not to be used [**]. At no time shall the physical Adimab Materials delivered by Adimab to Arsanis be [**] for any purpose. Arsanis shall use Adimab Materials in compliance with all applicable laws and regulations.
Appears in 4 contracts
Samples: Option and License Agreement, Option and License Agreement (Arsanis, Inc.), Option and License Agreement (Arsanis, Inc.)
Limits on Use of Adimab Materials. Arsanis Adagio understands and agrees that Adimab Materials may have unpredictable and unknown chemical properties, that they are to be used with caution, and that, except as expressly permitted by Article 3 (License and Assignment; Development & Commercialization) following exercise of the Option), they are not to be used [**]for testing in or treatment of humans. At no time shall the physical Adimab Materials delivered by Adimab to Arsanis Adagio be [**] used in humans for any purpose. Arsanis Adagio shall use Adimab Materials in compliance with all applicable laws and regulations.
Appears in 1 contract
Samples: Assignment and License Agreement (Adagio Therapeutics, Inc.)